Pay in 4 interest-free payments of $5.27 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
TGF-beta1-mediated repression of SLC7A11 drives vulnerability to GPX4 inhibition in hepatocellular carcinoma cells
It does not replace any of them
Understand their policies on order changes, delivery timelines, and responsiveness to quality concerns
References NHS: British Skin Foundation: PubMed (UK access): NICE (National Institute for Health and Care Excellence):
Our commitment to science-backed ingredients and advanced liposomal delivery systems ensures optimal bioavailability and efficacy
US$ 27.49
US$ 27.54
US$ 28.58
US$ 20.77
US$ 24.69
US$ 26.73
US$ 27.73
